Correlation Between Bank Hapoalim and Teva Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Bank Hapoalim and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Hapoalim and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank Hapoalim and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on Bank Hapoalim and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Hapoalim with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Hapoalim and Teva Pharmaceutical.

Diversification Opportunities for Bank Hapoalim and Teva Pharmaceutical

-0.72

Correlation Coefficient

Bank Hapoalim  Teva Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Bank and Teva is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Bank Hapoalim and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and Bank Hapoalim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Hapoalim are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of Bank Hapoalim i.e., Bank Hapoalim and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between Bank Hapoalim and Teva Pharmaceutical

Assuming the 90 days trading horizon Bank Hapoalim is expected to generate 0.47 times more return on investment than Teva Pharmaceutical. However, Bank Hapoalim is 2.11 times less risky than Teva Pharmaceutical. It trades about 0.22 of its potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about -0.2 per unit of risk. If you would invest  426,648  in Bank Hapoalim on December 29, 2024 and sell it today you would earn a total of  75,352  from holding Bank Hapoalim or generate 17.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Bank Hapoalim  vs.  Teva Pharmaceutical Industries

Bank Hapoalim

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Bank Hapoalim are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bank Hapoalim sustained solid returns over the last few months and may actually be approaching a breakup point.

Teva Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Teva Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Bank Hapoalim and Teva Pharmaceutical

The main advantage of trading using opposite Bank Hapoalim and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Hapoalim position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.

The idea behind Bank Hapoalim and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.